Nonlinear chromatin configurations can juxtapose widely separated elements within a genomic locus; however, it remains unclear how these structures are established and contribute to transcriptional control. A 5 0 -remote locus control region (LCR) regulates the human growth hormone (hGH-N) gene. HSI, a pituitary-specific component of the hGH LCR, establishes a domain of polymerase II (PolII) transcription 5 0 to hGH-N. Repression of this transcriptional domain by HSI deletion or PolII blockade decreases hGH-N expression. Here, we show that hGH-N activation is accompanied by positioning of the hGH-N promoter to this LCR transcriptional domain. Selectively blocking LCR transcription inhibits the formation of this active 'looped' conformation. Thus, HSI is crucial for establishing a domain of noncoding PolII transcription, and this domain is intimately linked with chromatin organization of the active hGH-N locus. This integration of LCR transcription with chromatin reconfiguration constitutes a robust pathway for long-range gene activation.
INTRODUCTION
Long-range controls have a crucial and often predominant role in metazoan gene activation (Ho et al, 2004; Dean, 2006) . Mechanisms of long-range gene activation have been grouped into several structural models (Forsberg & Bresnick, 2001; Ho et al, 2004; Dean, 2006) . However, the degree to which these models accurately reflect the full array of locus control region (LCR) functions remains to be determined and might vary among loci. The human growth hormone (hGH) cluster contains one pituitary-specific hGH-N gene and four placenta-specific paralogues (Fig 1A; Chen et al, 1989) . These five genes are activated by a set of LCR determinants located 15-32 kb upstream of the cluster ( Jones et al, 1995; Su et al, 2000; Ho et al, 2002) . The positioning of a B-lymphocyte-specific gene, CD79b, between the pituitary-specific HSI and the hGH-N promoter increases the complexity of the hGH gene cluster (Bennani-Baiti et al, 1998) , as does the location of the more distal HSIII-HSV elements within introns of the striated muscle sodium channel gene, SCN4A (Fig 1A) . Defining how this complex locus achieves robust and tissue-specific expression of its corresponding genes should determine crucial relationships between chromatin structure and gene regulatory pathways.
Previous studies have shown that the hGH LCR and the hGH-N promoter are encompassed within a 32 kb domain of acetylated histones H3 and H4 in pituitary chromatin (Elefant et al, 2000) ; this domain is centered at HSI,II. In mouse transgenic models, selective deletion of the pituitary-specific HSI results in the loss of histone acetylation throughout the LCR and a marked decrease in hGH-N transcription (Ho et al, 2006) . HSI is also crucial for establishing a pituitary-specific 'domain of transcription' that encompasses the LCR and the adjacent CD79b gene. Repression of transcription in the CD79b subregion of this domain, by insertion of a polymerase II (PolII) termination element between HSI and CD79b, results in a marked reduction in hGH-N expression (Ho et al, 2006) . The mechanistic link between the HSI-dependent domain of noncoding transcription and enhancement of hGH-N expression is investigated further in this paper. A comparison of the higher order chromatin configurations of the active and silent hGH loci supports a model in which the promoter activity of hGH-N is enhanced by its positioning into the PolII-enriched environment of the LCR transcriptional domain.
RESULTS AND DISCUSSION Formation of an HSI-dependent chromatin conformation
In contrast to the domain of histone acetylation that directly links the hGH LCR with the hGH-N promoter, the domain of PolII transcription at the active hGH locus, which encompasses the LCR and adjacent CD79b region, is separated from the active hGH-N gene by a nontranscribed gap (Ho et al, 2006) . To define further the structure of the active hGH locus, we carried out chromatin immunoprecipitation (ChIP) analysis of histone H3 lysine 4 trimethylation (H3K4-me3) at the hGH/P1 transgene locus. H3K4-me3 modifications are associated with active chromatin structure and often tightly linked to PolII elongation (Gerber & Shilatifard, 2003; Berger, 2007) . The hGH/P1 transgene extends from À40 to þ 45 kb relative to the transcriptional start site of hGH-N (Fig 1A) . The H3K4-me3 modifications at the active hGH/P1 transgene locus in the mouse pituitary paralleled PolII distribution; they extended through the LCR and adjacent CD79b region, and were separated from the hGH-N promoter by an intervening gap of unmodified chromatin. The modifications were greatly diminished when HSI was deleted (Fig 1B) . The concordant gaps in PolII occupancy and H3K4-me3 modification between the LCR and the hGH-N promoter suggested that activation of the hGH-N promoter might be mediated by nonlinear interactions with its LCR.
The higher order configuration of the active hGH-N locus was explored by using chromosome conformation capture (3C; Cullen et al, 1993; Dekker et al, 2002; Tolhuis et al, 2002) . Conditions were established in which the BglII restriction enzyme effectively and reproducibly digests primary chromatin preparations (Fig 2A;  supplementary Fig 1 online) pituitary chromatin (grey bars) or hGH/P1 liver chromatin (white bars). Each histogram bar represents the ratio of the DNA amplification signal from Southern blot detected in the immunoprecipitated sample to that in the corresponding input sample. Each ratio was normalized to the corresponding ratio for a DNA segment within the endogenous skeletal muscle-specific mMyoD gene (Weintraub et al, 1991; Sawado et al, 2003) . Each ratio, after normalization to mMyoD, is expressed on the Y axis in arbitrary units. The amplimer set corresponding to each set of bars is noted below the X axis. The site of hGH-N transcription initiation is noted below the X axis (angled arrow) and the previously defined 'LCR domain of transcription' is indicated by the labeled bracket below the histogram. All comparisons between hGH/P1 modifications in the pituitary compared with liver are significant (Po0.001) except at À37 and p9. Comparisons between hGH/P1 and hGH/P1DHSI between À25 and Ex2 inclusive are significant (Po0.001). Comparisons between hGHDHSI pituitary and hGH/P1 liver are significant only at Ex2 (Po0.01). H3K4me3, histone H3 lysine 4 trimethylation; hGH, human growth hormone; LCR, locus control region. transgene. Each BglII site is indicted below the locus map by a tick mark. The position of each of the PCR primers is also shown (arrowheads); the GH/CS primer, common to all four GH-related genes (large arrowheads), functioned as the anchor primer in these studies. The four upstream primers detect individual BglII fragments that contain HSV, p4, HSII, CD79b or p1 regions. (B) Summary of the 3C analyses in hGH/P1(TerF) pituitary (Pit) chromatin. 3C assays were performed on pituitaries (black bars) or livers (white bars) of mice representing two hGH/P1 transgenic lines and on pituitaries of mice representing two hGH/P1(DHSI) lines (grey bars). GH/CS, the anchor primer for these studies, was paired with each of the four 5 0 primers in the PCR analysis of the ligation products. The panels below the histogram show representative ethidium bromide-stained agarose gels containing the indicated PCR amplification products; the distinct bands representing the hGH-N-and hGH-V/hCS-specific ligation products are indicated by arrowheads at the left of the top panel. The intensities of the bands were quantified. Lane C (control) contains the PCR amplifications of the ligation products of a BglII-digested hGH/P1 plasmid DNA. Lane marked À contains the products of the assay performed using the hGH/P1 pituitary chromatin preparation in the absence of T4 DNA ligase. The band in the CD79b (À) sample represents a background amplification product that is insensitive to BglII. The histogram values represent ratios of the signal of the hGH-N-specific ligation product to the combined placental genespecific ligation products (supplementary Figs 1,2 online). Each histogram bar represents the mean±s.d. of four or more independent studies on each of the two transgenic lines. In comparison of the value obtained from hGH/P1 pituitary chromatin to the indicated value, a single asterisk indicates Po0.01 and a double asterisk indicates Po0.001. 3C, chromosome conformation capture; hGH, human growth hormone; LCR, locus control region.
LCR looping mediates gene activation Y. Ho et al Ho et al, 2006) . The analysis of liver chromatin (nonexpressing cells) from these mice (Fig 2B, white bars) showed that the efficiency of ligation of the hGH-N promoter fragment to each of the 5 0 restriction fragments decreased as the distance between the GH/CS anchor and upstream primers increased. This relationship is consistent with a linear conformation of the cluster in liver chromatin (Dekker et al, 2002) . By contrast, the analysis of pituitary chromatin from the same two hGH/P1 transgenic lines (Fig 2B, black bars) showed that the ratio of ligation products shifted in favour of the fragment containing the hGH-N promoter when the anchor GH/CS primer was paired with the primer associated with HSI,II or adjacent CD79b restriction fragments. This pattern of ligation frequencies indicated a close positioning between the HSI,II region and the hGH-N promoter despite the intervening linear 14.5 kb. The PCR products generated by amplification between the GH/CS primer and the HSII primer were purified and sequenced to confirm their identity. These data support a selective, long-range interaction between the HSI,II region and the hGH-N promoter.
To validate the above results, a reciprocal 3C assay was performed using HSII as the anchor primer (Fig 3A) . In these assays, the combination of the HSII anchor and GH/CS primer generated the expected doublet. Ligations to each of the other primers generated a single, specific PCR product (Fig 3B) . For each set of amplifications, the PCR signal was normalized to the random ligation control (Fig 3B, lane C , ligation of hGH/P1 plasmid DNA) and to ligation fragments generated from the endogenous, universally expressed ERCC3 locus (Palstra et al, 2003; Fig 3C) . The high frequency of ligation between the HSII anchor and CD79b in both liver and pituitary chromatin samples is consistent with their proximity to the locus in the linear structure (Liu & Garrard, 2005) . By contrast, there was a significantly higher ligation frequency between the HSII anchor and the hGH-N promoter fragment in pituitary compared with liver chromatin from the same mouse (Fig 3B) . The region between CD79b and hGH-N, represented by the p1 fragment, had a lower ligation frequency to HSII (Fig 3B) . The low-level association between the HSII anchor and the p1 fragment is consistent with their linear proximity. The similar ligation frequency between p1 and the HSII anchor fragment in liver chromatin from the same mouse (Figs 2,3) further suggests that these low-level interactions do not contribute significantly to the activating function of the hGH LCR. These 3C results confirmed a specific close contact between the HSI,II region and the hGH-N promoter in pituitary chromatin.
Next, structural alterations at the active hGH locus were assessed for their dependence on HSI. The 3C assay was carried out using pituitary chromatin from two hGH/P1(DHSI) transgenic mouse lines (Fig 2B, grey bars) . PCR analyses showed a pattern of ligation products in the pituitary chromatin of the hGH/P1(DHS)I mice that was essentially identical to those at the inactive hGH/P1 locus in liver chromatin (Fig 2B, compare grey with white bars) . Thus, looping of HSI,II to the active hGH-N promoter in pituitary chromatin is dependent on HSI. The HSI dependency of HSI,II juxtaposition to the hGH-N promoter was confirmed by using the HSII anchor primer (Fig 3B, grey bars) . This HSI dependency links the specific chromatin conformation at the hGH locus in the pituitary to enhancement of hGH-N transgene expression (Ho et al, 2006) .
In addition to the contact between the HSI,II region and the hGH-N promoter, 3C analysis also showed that the HSI,II region comes into close proximity with HSIII-HSV; the ligation frequency between HSII and HSIII-HSV fragments is significantly greater in the pituitary than in the liver of the hGH/P1 mouse (Fig 3B) . Of note, this interaction is maintained in the HSI-deleted transgene. Limited functional tests of HSIII-HSV have suggested that this region might have boundary functions ( Jones et al, 1995) , and acetylation of histones H3/H4 at HSV is also unique in its HSI independence (Ho et al, 2006) . Surprisingly, although the HSI,II fragment crosslinks to both the HSIII-HSV region and the hGH-N promoter, there is no evidence for crosslinking between HSIII-HSV and the hGH-N promoter. This relationship might reflect dynamic switching of the HSI,II interactions between HSV and the hGH-N promoter (Liu & Garrard, 2005) . High-resolution 3C analyses of the HSIII-HSV region will be useful in exploring further the configuration of this set of long-range interactions.
The chromatin conformations at the hGH transgene locus in pituitary and liver, and at the pituitary locus lacking an active HSI are schematically compared (Fig 3D) . The HSI-dependent interaction between the hGH-N promoter and the LCR/CD79b domain of transcription is specific to the active locus in the pituitary. In the absence of HSI, this interaction is lost, whereas the interaction between HSII and the more 5 0 end of the LCR is retained.
Looping is dependent on the LCR domain of transcription
To define further the basis for the interaction between the hGH-N promoter and the HSI,II regions, we determined whether looping was dependent on the presence of the LCR noncoding transcriptional domain or, alternatively, whether HSI might be sufficient for this interaction. We have previously shown that insertion of a PolII termination element (TerF) 3 0 to HSI (Fig 4A, hGH/P1(TerF) transgene) selectively interrupts the downstream CD79b transcriptional subdomain and results in a six-to eightfold decrease in hGH-N transgene expression (Ho et al, 2006; Fig 4A, inset) . This insertion has no significant impact on HSI formation or on HSIdependent histone acetylation (Ho et al, 2006) . 3C assays were performed on pituitary chromatin from two hGH/P1(TerF) transgenic mouse lines. The analyses, using both GH/CS and HSII primers as anchors in separate studies (Fig 4B,C) , showed that TerF insertion effectively blocked looping between HSI,II and the hGH-N promoter. The frequency of the crosslinking between HSI,II and the hGH-N promoter was reduced to the level seen in the absence of HSI (compare Figs 2-4) . Interactions between HSI,II and HSIII-HSV regions were retained in the presence of TerF (Fig 4C; data summarized in Fig 4D) . We conclude that the full chromatin conformation at the active hGH locus is dependent on a functional LCR/CD79b domain of transcription. HSI, in the absence of this function, is not sufficient for chromatin reconfiguration and gene activation.
Activation and enhancement of hGH-N transcription by its LCR reflects a complex and multifaceted process. The crucial role of HSI in this process is evident from its essential functions in establishing linear domains of histone modification within the locus and in establishing the domain of noncoding PolII enrichment 5 0 to the hGH cluster. The formation of the HSIdependent LCR/CD79b domain of transcription seems to have a crucial function in the gene activation process; interruption of this domain by insertion of a PolII terminator results in the loss of the LCR looping mediates gene activation Y. Ho et al chromatin conformation specific to the active locus and in a corresponding decrease in hGH-N expression. Remarkably, disruption of the LCR transcriptional domain does not alter histone acetylation throughout the locus (Ho et al, 2006 ). This suggests that the HSI-dependent histone acetylation at the hGH locus is independent of LCR transcription and is, by itself, insufficient for hGH-N activation. These relationships support a model in which histone acetylation constitutes an early step in Fig 2A. (B) HSI-dependent association between HSI,II and the hGH-N promoter, and evidence for a pituitary (Pit)-specific interaction between HSII and HSIII-HSV regions. The semiquantitative PCR analyses of 3C ligation products were normalized to parallel analyses of the endogenous ERCC3 locus (C). Each bar represents the mean±s.d. of four independent assays of the indicated chromatin samples: hGH/P1 pituitary chromatin (black bars), hGH/P1(DHSI) pituitary chromatin (grey bars) and control liver chromatin (white bars). Lane C contains a PCR analysis of ligation products of BglII-digested hGH/P1 plasmid DNA and represents random ligation of equimolar quantities of each of the BglII fragments in the locus under the conditions of the assay. The ligation efficiency shown on the Y axis was calculated using the equation (signal tissue /signal random control )/(signal ERCC3 ligation /signal ERCC3 loading ). (C) 3C analysis of the control ERCC3 locus. The indicated head-to-head ligation frequency of two adjacent BglII fragments released from the ubiquitously expressed ERCC3 locus during the 3C analysis was determined and used as an internal control for each 3C assay. PCR within a unique BglII fragment was used as the loading control for each analysis. (D) A looping model of pituitary-specific hGH-N activation. The 3C studies of the hGH/P1 and hGH/P1(DHSI) transgene loci in the pituitary and the hGH/P1 transgene locus in the liver are summarized in a diagrammatic format. 3C, chromosome conformation capture; hGH, human growth hormone.
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CD79b These studies showed that an active LCR/CD79b domain of transcription is essential and a probable prerequisite to looping between HSI,II and the hGH-N promoter. These data, along with our previous studies of PIT-1 trans-acting factor binding in HSI and the promoter of hGH-N (Shewchuk et al, 1999; Ho et al, 2002) , support a model in which occupancy of PIT-1 at both HSI and the hGH-N promoter triggers interactions between the two regions that are subsequently stabilized by the noncoding transcriptional activity (Fig 3D) . The final chromatin conformation at the active locus places the hGH-N promoter in close proximity to the PolIIenriched LCR/CD79b transcriptional domain. This relocation of a promoter into an environment rich in elongating PolII is reminiscent of reports of close physical relationships between certain activated genes and PolII-enriched subnuclear 'transcriptional factories' (Iborra et al, 1996; Grande et al, 1997; Osborne et al, 2004; Ragoczy et al, 2006) . Whether hGH-N gene activation is linked to an association with subnuclear transcription factories, or whether the juxtaposition of the promoter with the local accumulation of PolII within its LCR is sufficient will be of interest in future studies. Irrespective of this relationship, the observation that loop formation and expression at the hGH locus are both lost when LCR transcription is interrupted suggests that formation of this domain and looping are interdependent and mutually sustaining processes in the pathway of long-range transcriptional control.
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METHODS
Transgenic mouse lines. All transgenic mouse lines used in this study were established as described previously; the hGH/P1 mouse lines were 809F and 811D (copy numbers of transgene are 4 and 5, respectively; Su et al, 2000), hGH/P1(DHSI) lines were 960G and 969E (copy numbers 3 and 4; Ho et al, 2002) , and hGH/ P1(TerF) lines were 1301C and 1301G (copy numbers are 3 and 5; Ho et al, 2002) . ChIP and 3C assays were performed using 3-to 4-month-old compound transgenic mouse lines carrying hGH/P1, hGH/P1(DHSI) or hGH/P1(TerF) transgene along with a growth hormone-releasing factor (hGRF) transgene under the control of the metallothionine promoter. The hGRF transgene stimulates selective expansion of the somatotrope population with consequent pituitary hypertrophy (Mayo et al, 1988) . Chromatin immunoprecipitation assays. ChIP was performed as described previously (Ho et al, 2006) . The sequences of the primers have also been described previously (Ho et al, 2006) . Each ratio of bound fraction to input was normalized to the corresponding ratio for a DNA segment within the endogenous skeletal muscle-specific mMyoD gene (Weintraub et al, 1991; Sawado et al, 2003) . Chromatin conformation capture assay. The 3C procedure was performed as described previously (Tolhuis et al, 2002) , but with modifications as described in the supplementary information online. PCR analysis of chromatin conformation capture ligation products. The semiquantitative PCR analysis is described in the supplementary information online. The ligation efficiency was determined as a ratio of products ligated to the hGH-N promoter relative to the hCS/hGH-V promoter fragments when the GH/CS primer functioned as the anchor primer ( Figs 2B,4B) , or relative to an internal control at an endogenous ercc3 locus when the HSII primer functioned as the anchor primer ( Figs 3B,4C ). Data were plotted as mean þ s.d. and t-tests were performed to determine the level of significance in binary comparisons. Supplementary information is available at EMBO reports online (http://www.emboreports.org). 
